Literature DB >> 6694753

An antigenic difference between cells forming early and late haematopoietic spleen colonies (CFU-S).

R A Harris, P M Hogarth, L J Wadeson, P Collins, I F McKenzie, D G Penington.   

Abstract

Murine pluripotent haematopoietic stem cells have generally been assayed by their ability to form macroscopic colonies of haematopoietic cells in the spleens of heavily irradiated recipient mice (colony-forming unit-spleen or CFU-S assay). However, recent evidence suggests that there are distinct subpopulations of CFU-S. Most spleen colonies present 7-8 days after injection consist of differentiated erythroid cells, contain no primitive myeloid or erythroid precursor cells and disappear from the spleen within 3 days, whereas the majority of colonies present at 10-12 days contain primitive precursors, are multilineal and cannot be detected at 7-8 days. Furthermore, many 10-day-old spleen colonies do not contain cells capable of forming spleen colonies in secondary irradiated recipients (an index of the self-renewal capacity of stem cells) whereas at day 14 almost all colonies contain these CFU-S. These studies suggest that only when colonies are scored at or later than 11-12 days is the spleen colony technique adequate for the assay of multipotential stem cells. We now report an antigenic difference between subpopulations of CFU-S forming early (day 8) and late (day 14) spleen colonies which has been used to purify multipotential haematopoietic stem cells from murine bone marrow.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694753     DOI: 10.1038/307638a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  8 in total

1.  Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow.

Authors:  Ken-ichi Minehata; Masaki Takeuchi; Yoko Hirabayashi; Tohru Inoue; Peter J Donovan; Minoru Tanaka; Atsushi Miyajima
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Long-term cultured B lymphocytes and their precursors reconstitute the B-lymphocyte lineage in vivo.

Authors:  J I Kurland; S F Ziegler; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

4.  Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.

Authors:  Grant A Challen; Margaret A Goodell
Journal:  Exp Hematol       Date:  2010-03-03       Impact factor: 3.084

Review 5.  CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis.

Authors:  Alessandra Rodriguez Y Baena; Bryce A Manso; E Camilla Forsberg
Journal:  Exp Hematol       Date:  2021-10-22       Impact factor: 3.249

6.  Isolation of a candidate human hematopoietic stem-cell population.

Authors:  C M Baum; I L Weissman; A S Tsukamoto; A M Buckle; B Peault
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Indirect visualization of hematopoietic colony-forming stem cell (CFUs) as a possible target cell for Mycoplasma arthritidis.

Authors:  A V Sanin
Journal:  Experientia       Date:  1987-04-15

8.  Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

Authors:  J L Spivak; R R Smith; J N Ihle
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.